.Pharmacolibrary.Drugs.C_CardiovascularSystem.C09B_AceInhibitorsCombinations.C09BX03_RamiprilAmlodipineAndHyd.RamiprilAmlodipineAndHyd .Pharmacolibrary.Drugs.C_CardiovascularSystem.C09B_AceInhibitorsCombinations.C09BX03_RamiprilAmlodipineAndHyd.RamiprilAmlodipineAndHyd| name: | RamiprilAmlodipineAndHydrochlorothiazide |
| ATC code: | C09BX03 | route: | oral |
| n-compartments | 1 |
Ramipril, amlodipine, and hydrochlorothiazide is a fixed-dose combination antihypertensive medication used for the management of high blood pressure (hypertension). Ramipril is an angiotensin-converting enzyme (ACE) inhibitor, amlodipine is a calcium channel blocker, and hydrochlorothiazide is a thiazide diuretic. This combination is used in patients whose blood pressure is not sufficiently controlled by monotherapy. It is approved for use in several countries.
Estimated pharmacokinetic model parameters for typical healthy adult population for oral administration; no published pharmacokinetic model exists for the fixed combination product.